《半日速报》恒指跌574点 创科跌逾4% 中生制药、联邦制药、远大医药、中广核新能源、三一国际创新高
恒指半日收26,193点,跌574点或2.1%。国指跌240点或2.2%,报10,488点。活跃重磅股表现:建行(00939.HK) 收6.37元,下跌2.5%;友邦(01299.HK) 收75.75元,下跌2.4%;腾讯(00700.HK) 收397.2元,下跌2.2%;汇控(00005.HK) 收50.75元,下跌2%;平安(02318.HK) 收87.25元,下跌2%;工行(01398.HK) 收5.38元,下跌2%;异动恒指及国指成份股:创科(00669.HK) 收64.6元,下跌4.3%;龙湖(00960.HK) 收37元,下跌4.3%;中信股份(00267.HK) 收8.79元,下跌3.8%;万科(02202.HK) 收31.35元,下跌3.7%;碧桂园(02007.HK) 收10.5元,下跌3.7%;金沙(01928.HK) 收34.65元,下跌3.6%;融创中国(01918.HK) 收44.2元,下跌3.6%;银娱(00027.HK) 收50.85元,下跌3.4%;邮储银行(01658.HK) 收4.93元,下跌3.3%;华润置地(01109.HK) 收37.1元,下跌3.1%;中海油(00883.HK) 收10.72元,下跌3.1%;旺旺(00151.HK) 收6.14元,下跌3%;中生制药(01177.HK) 收12.6元,上升2.1%,创新高;异动综合中小型股:联邦制药(03933.HK) 收6.11元,上升4.4%,创新高;远大医药(00512.HK) 收5.52元,上升4.3%,创新高;中广核新能源(01811.HK) 收1.6元,上升1.3%,创新高;三一国际(00631.HK) 收5.2元,上升0.2%,创新高;~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.